🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: * One way tumors are able to grow is by forming new blood vess...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-12
Trial ID
NCT01372813
Treatments Being Tested
The purpose of this research study is to determine the safety and tolerabil...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-07
Trial ID
NCT00496665
Treatments Being Tested
This is a multi-centre, phase II study to assess the efficacy and safety of...
Status
Completed
Location
Research Site
Start Date
2007-07
Trial ID
NCT00508001
Treatments Being Tested
A Phase I open label study to asses the safety and tolerability of ZD6474 i...
Status
Completed
Location
Research Site
Start Date
2005-08
Trial ID
NCT00507091
Treatments Being Tested
Open-label Study to Evaluate the Safety and Tolerability of Vandetanib 300 ...
Status
Completed
Location
Research Site
Start Date
2012-11
Trial ID
NCT01661179
Treatments Being Tested
To assess the objective response rates (by RECIST) to ZD6474 100, 200 and 3...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252746
Treatments Being Tested
The purpose of this study is to give patients with medullary thyroid cancer...
Status
Completed
Location
Research Site
Start Date
2012-06-08
Trial ID
NCT01496313
Treatments Being Tested
This randomized, double-blind phase II trial is to assess the efficacy and ...
Status
Completed
Location
Research Site
Start Date
2008-02
Trial ID
NCT00659438
Treatments Being Tested
The current study aims to explore the potential advantages of anti-cancer t...
Status
Recruiting
Location
West China hospital
Start Date
2021-06-01
Trial ID
NCT06482086
The purpose of this study is to evaluate the effect of patient outreach pro...
Status
Completed
Location
Investigational Site Number : 301
Start Date
2011-02-25
Trial ID
NCT01298323
Treatments Being Tested